Heart rhythm breakthrough? diabetes drug tested for rare syndrome
NCT ID NCT07146880
Summary
This study is testing if a drug called Empagliflozin, commonly used for diabetes, can help control Brugada syndrome, a rare genetic heart condition that can cause dangerous irregular heartbeats. Researchers will give the drug to 10 adult patients for three months to see if it improves their heart's electrical patterns on an ECG test and to monitor for any side effects. The goal is to find a new treatment option to better manage this serious condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRUGADA SYNDROME (BRS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital
Taipei, Taiwan, 100, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.